1 hour ago
Eli Lilly (LLY) Stock Dips Following $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline
Eli Lilly (LLY) stock declined after unveiling a $2.8B AtaiBeckley acquisition, adding late-stage depression treatments including FDA breakthrough therapy BPL-003.
The post Eli Lilly (LLY) Stock Dips Following $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline appeared first on Blockonomi.
Source: Blockonomi →Related News
- 26 minutes ago
Intel (INTC) Shares Decline 3.4% Despite Analyst’s Bullish $115 Price Target Upg...
- 27 minutes ago
Tech Stocks Stumble as Semiconductor Sector Extends Two-Day Slide
- 34 minutes ago
Taiwan Semiconductor (TSM) Slips Despite Strong Q2 Beat and Bullish Analyst Upgr...
- 35 minutes ago
Vertiv (VRT) Stock: Baird Initiates Coverage With $370 Price Target and Outperfo...
- 35 minutes ago
ServiceNow (NOW) Stock Receives Dual Upgrades Ahead of Q2 Results